阿替利珠单抗联合贝伐珠单抗与索拉非尼应用于不可切除肝细胞癌的疗效对比
评价者：胡晓云1, 陈锦章1, 文献合成者：王森锐2

Efficacy Comparison Between Atezolizumab Plus Bevacizumab and Sorafenib in Unresectable Hepatocellular Carcinoma
Reviewers: HU Xiao-yun1, CHEN Jin-zhang1, Literature Co-worker: WANG Sen-rui2